Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|July 16, 2019
Epigenetic pharmacotherapy for substance use disorderGregory C SartorAdvances in Drug and Alcohol Research|January 5, 2023
Noncoding RNA therapeutics for substance use disorderSeyed Afshin Seyednejad, Gregory C SartorNeuropharmacology|September 18, 2020
BET bromodomains as novel epigenetic targets for brain health and diseaseMandakini B Singh, Gregory C SartorNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 22, 2013
Post-retrieval extinction attenuates cocaine memoriesGregory C Sartor, Gary Aston-JonesThe European Journal of Neuroscience|October 9, 2012
Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preferenceGregory C Sartor, Gary Aston-JonesPsychopharmacology|October 4, 2025
The effects of low-dose ketamine and (2R,6R)-Hydroxynorketamine on affective behaviors associated with protracted oxycodone withdrawalMichael J Lehane, Gregory C SartorThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2012
A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preferenceGregory C Sartor, Gary S Aston-JonesFrontiers in Genetics|June 28, 2012
The Emerging Role of Non-Coding RNAs in Drug AddictionGregory C Sartor, Georges St Laurent, Claes WahlestedtNeuropharmacology|March 22, 2022
Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaineMandakini B Singh, Christopher J Babigian, Gregory C SartorDrug and Alcohol Dependence|October 21, 2023
The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatementCaryssa R Drinkuth, Michael J Lehane, Gregory C SartorPageof 3